Tharimmune Inc (THAR)
0.3651
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.3651
0.00 (0.00%)
After-Hours: 20:00
Tharimmune Free Cash Flow (Quarterly): -2.825M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.825M |
| December 31, 2023 | -1.415M |
| September 30, 2023 | -0.909M |
| June 30, 2023 | -1.511M |
| March 31, 2023 | -3.465M |
| December 31, 2022 | -0.8927M |
| September 30, 2022 | -1.549M |
| Date | Value |
|---|---|
| June 30, 2022 | -1.388M |
| March 31, 2022 | -2.728M |
| December 31, 2021 | -0.0077M |
| September 30, 2021 | -0.3168M |
| June 30, 2021 | -0.2694M |
| March 31, 2021 | -0.4924M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-3.465M
Minimum
Mar 2023
-0.0077M
Maximum
Dec 2021
-1.367M
Average
-1.388M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | 44.92M |
| Mirum Pharmaceuticals Inc | 15.20M |
| NovaBay Pharmaceuticals Inc | -1.574M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |